MM
Michael Matly
OtherActiveCo-Founder/Managing Partner - 111° West Capital
40
Investments
0
Exits
—
AUM
0.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Michael Matly.
Investment Thesis & Strategy
Michael Matly, through 111° West Capital, invests in various stages of AI/ML, analytics, biotech, health & hospital services, and health IT companies. They likely seek innovative companies with strong growth potential within these sectors.
Investment Activity
Deals per year over the last 1 years
2
2008Portfolio Companies
Selected investments from their portfolio of 40 companies
M
MINDBODY
Other · , 0
T
Tobira Therapeutics
Other · , 0
A
Asthmatx
Other · , 0
F
FinPay
Other · , 0
G
Glaukos
Other · , 0
B
Bayhill Therapeutics
Other · , 0
A
ARYx Therapeutics
Other · , 0
T
TigerConnect
Other · , 0
N
NeurogesX
Other · , 0
K
KFx Medical
Other · , 0
m
moksha8 Pharmaceuticals
Biotech · Seed, 2008
S
SI-BONE
Healthcare · Seed, 2008
Frequently Asked Questions
Michael Matly focuses on Seed stage investments.
Related Investors
Bill Coughran
San Francisco, United States · 104 deals
Dave Lambert
San Francisco, United States · 101 deals
Arun Mathew
San Francisco, United States · 99 deals
Ash Rust
San Francisco, United States · 96 deals
Alex Tran
San Francisco, United States · 95 deals
Randy Williams
San Francisco, United States · 95 deals